![1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline structure](/static/products/843/843671-75-0.png)
1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline
TL;DR: 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline (CAS 843671-75-0) is a chemical compound with molecular formula C22H24N4O2S and molecular weight 408.16 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
1-cyclopentyl-3-(3,4-dimethylphenyl)sulfonyl-2H-imidazo[4,5-b]quinoxaline
Also Known As: 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline, F3225-0756, 1-cyclopentyl-3-(3,4-dimethylbenzenesulfonyl)-1H,2H,3H-imidazo[4,5-b]quinoxaline, 1-cyclopentyl-3-(3,4-dimethylphenyl)sulfonyl-2H-imidazo[4,5-b]quinoxaline, 1-cyclopentyl-3-[(3,4-dimethylphenyl)sulfonyl]-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline
| Molecular Formula | C22H24N4O2S |
|---|---|
| Molecular Weight | 408.16 g/mol |
| LogP | 4.16204 |
| Topological Polar Surface Area | 66.4 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Exact Mass | 408.162 |
| Heavy Atoms | 29 |
| Complexity | 1202.6578 |
Chemical Identifiers
| CAS Number | 843671-75-0 |
|---|---|
| SMILES | CC1=C(C=C(C=C1)S(=O)(=O)N2CN(C3=NC4=CC=CC=C4N=C32)C5CCCC5)C |
Product Overview
1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline (CAS 843671-75-0), with molecular formula C22H24N4O2S and molecular weight 408.16 g/mol. IUPAC: 1-cyclopentyl-3-(3,4-dimethylphenyl)sulfonyl-2H-imidazo[4,5-b]quinoxaline.
Chemical Property Profile of 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline
Property Insights of 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline
The XLogP value of 4.16204 indicates that 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 66.4 Ų falls within the moderate polarity range, balancing permeability and solubility for 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline. Following Lipinski's Rule of Five, 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline has 0 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline?
The CAS number of 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline is 843671-75-0.
What is the molecular formula of 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline?
The molecular formula of 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline is C22H24N4O2S.
What is the molecular weight of 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline?
The molecular weight of 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline is 408.16 g/mol.
Where can I buy 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline?
You can request a quote for 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline?
Yes, KEHONG BIO provides custom synthesis services for 1-cyclopentyl-3-((3,4-dimethylphenyl)sulfonyl)-2,3-dihydro-1H-imidazo[4,5-b]quinoxaline and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.